Kunming Pharmaceutical Corp. is a company that is involved in the manufacture and sale of natural drugs, as well as the wholesale and retail of other drugs. It is the largest pharmaceutical enterprise in Yunnan.
As of December 31, 2007, the Company had five major subsidiaries and associates. Headquartered in Kunming, Yunnan Province, China, the Company distributes its products in domestic market and to overseas markets.
The Company offers its major products under three categories: Artemether series, consisting of artemether injections, capsules, and tablets for the treatment of subtertian malaria; Sanqi series, for the treatment of cardiovascular and cerebrovascular diseases, and Gastrodine series, for the treatment of headache and neuralgia.
A medication is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Kunming is the capital and largest city of Yunnan province, People's Republic of China. Also known as Yunnan-Fu, today it is a prefecture-level city and the political, economic, communications and cultural centre of the province as well as the seat of the provincial government. The headquarters of many of Yunnan's large businesses are in Kunming. It was important during World War II as a Chinese military center, American air base, and transport terminus for the Burma Road. Located in the middle of the Yunnan–Guizhou Plateau, Kunming is located at an altitude of 1,900 metres above sea level and at a latitude just north of the Tropic of Cancer. As of 2014, Kunming has a population of 6,626,000 with an urban population of 4,575,000, and is located at the northern edge of Dian Lake, surrounded by temples and lake-and-limestone hill landscapes.
The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs.
H. Lundbeck A/S is a Danish international pharmaceutical company engaged in the research and development, production, marketing, and sale of drugs for the treatment of disorders in the central nervous system (CNS), including depression, schizophrenia, Alzheimer's disease and Parkinson's disease.
Artemether is a medication used for the treatment of malaria. The injectable form is specifically used for severe malaria rather than quinine. In adults, it may not be as effective as artesunate. It is given by injection in a muscle. It is also available by mouth in combination with lumefantrine, known as artemether/lumefantrine.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.
Bausch Health Companies Inc. is a multinational specialty pharmaceutical company based in Laval, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health, and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products.
The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery.
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow.
Artemether/lumefantrine, sold under the trade name Coartem among others, is a combination of the two medications artemether and lumefantrine. It is used to treat malaria caused by Plasmodium falciparum that is not treatable with chloroquine. It is not typically used to prevent malaria. It is taken by mouth.
Yunnan Baiyao is a proprietary traditional Chinese medicine marketed and used as an alternative hemostatic product with use in both human and veterinary alternative medicine. The safety and efficacy of Yunnan Baiyao has not been assessed or established by the FDA, European Medicines Agency, or the Australian Therapeutic Goods Administration. There is limited evidence regarding its effectiveness in preventing or treating hemorrhagic and pathological conditions in both humans and animals via oral administration. In a limited number human studies of small sample sizes, administration of Yunnan Baiyao has been shown to correlate with "reduced perioperative bleeding as well as bleeding in various ulcerative–hemorrhagic conditions". A retrospective case-controlled study found Yunnan Baiyao does not delay recurrence of clinical signs or improve survival in dogs with right atrial masses or pericardial effusion. There are multiple routes of drug administration. Yunnan Baiyao is sold in powder, tincture, plaster, paste, aerosol, or tablet form. The medicine, developed by Qu Huangzhang in 1902, is designated as one of two Class-1 protected traditional Chinese medicines which gives it 20 years of trade protection in China. Yunnan Baiyao products are manufactured and distributed by a state-owned enterprise, Yunnan Baiyao Group in Yunnan, China.
China Nepstar Chain Drugstore Ltd., which conducts business as China Nepstar, is China's largest retail drugstore chain, based on the number of directly operated stores.
The Kunming High-tech Industrial Development Zone is a state-level high-tech industrial zone established in 1992 in Northwest Kunming, Yunnan Province, China. It is administratively under Kunming Prefecture. It covers an area of 9 square kilometers. The zone is located in the northwest part of Kunming city, four kilometers from Kunming Railway Station and five kilometers from Kunming International Airport.
Kunming Medical University, previously known as Kunming Medical College, is a medical school located in Kunming City, Yunnan Province, China.
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products.
Project 523 is a code name for a 1967 secret military project of the People's Republic of China to find antimalarial medications. Named after the date the project launched, 23 May, it addressed malaria, an important threat in the Vietnam War. At the behest of Ho Chi Minh, Prime Minister of North Vietnam, Zhou Enlai, the Premier of the People's Republic of China, convinced Mao Zedong, Chairman of the Communist Party of China, to start the mass project "to keep [the] allies' troops combat-ready", as the meeting minutes put it. More than 500 Chinese scientists were recruited. The project was divided into three streams. The one for investigating traditional Chinese medicine discovered and led to the development of a class of new antimalarial drugs called artemisinins. Launched during and lasting throughout the Cultural Revolution, Project 523 was officially terminated in 1981.
Glenmark Pharmaceuticals Limited is a pharmaceutical company headquartered in Mumbai, India that was founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer; he named the company after his two sons. The company initially sold its products in India, Russia, and Africa. The company went public in India in 1999, and used some of the proceeds to build its first research facility. Saldanha's son Glenn took over as CEO in 2001, having returned to India after working at PricewaterhouseCoopers. By 2008 Glenmark was the fifth-biggest pharmaceutical company in India.
Amneal Pharmaceuticals, Inc. is a U.S.-domiciled publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.
Jazz Pharmaceuticals plc is a biopharmaceutical company based in Ireland. It was founded in 2003. One of the company's most significant products is the United States Food and Drug Administration (FDA) approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA).
Vyera Pharmaceuticals is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017.
